{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:29:14Z","timestamp":1789784954203,"version":"4.0.1"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100013014","name":"Barrow Neurological Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013014","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Arizona Alzheimer\u2019s Consortium"},{"name":"National Institute of Aging","award":["PO1AG014449"],"award-info":[{"award-number":["PO1AG014449"]}]},{"name":"National Institute of Aging","award":["RO1AG043375"],"award-info":[{"award-number":["RO1AG043375"]}]},{"name":"National Institute of Aging","award":["P30AG010161"],"award-info":[{"award-number":["P30AG010161"]}]},{"name":"National Institute of Aging","award":["P30AG042146"],"award-info":[{"award-number":["P30AG042146"]}]},{"name":"National Institute of Aging","award":["RF1AG081286"],"award-info":[{"award-number":["RF1AG081286"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-025-03349-y","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:55:26Z","timestamp":1738277726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["APOE\u03b54 alters ApoE and Fabp7 in frontal cortex white matter in prodromal Alzheimer's disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Marta","family":"Moreno-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia E.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Malek-Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott J.","family":"Mufson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"issue":"4","key":"3349_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5551\/jat.E499","volume":"14","author":"H Arai","year":"2007","unstructured":"Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, et al. Polymorphisms of apolipoprotein e and methylenetetrahydrofolate reductase in the Japanese population. J Atheroscler Thromb. 2007;14(4):167\u201371.","journal-title":"J Atheroscler Thromb"},{"issue":"4","key":"3349_CR2","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1590\/1678-4685-gmb-2017-0301","volume":"41","author":"Z Zhong","year":"2018","unstructured":"Zhong Z, Wu H, Wu H, Zhao P. Analysis of apolipoprotein E genetic polymorphism in a large ethnic Hakka population in southern China. Genet Mol Biol. 2018;41(4):742\u20139.","journal-title":"Genet Mol Biol"},{"issue":"11","key":"3349_CR3","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1590\/S0100-879X2007001100002","volume":"40","author":"AK Fuzikawa","year":"2007","unstructured":"Fuzikawa AK, Peixoto SV, Taufer M, Moriguchi EH, Lima-Costa MF. Apolipoprotein E polymorphism distribution in an elderly Brazilian population: the Bambui Health and Aging Study. Braz J Med Biol Res. 2007;40(11):1429\u201334.","journal-title":"Braz J Med Biol Res"},{"key":"3349_CR4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.11604\/pamj.2013.15.157.2320","volume":"15","author":"F Benyahya","year":"2013","unstructured":"Benyahya F, Barakat A, Ghailani N, Bennani M. Apolipoprotein E polymorphism in the population of northern Morocco: frequency and effect on lipid parameters. Pan Afr Med J. 2013;15:157.","journal-title":"Pan Afr Med J"},{"key":"3349_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03127-y","author":"J Fortea","year":"2024","unstructured":"Fortea J, Pegueroles J, Alcolea D, Belbin O, Dols-Icardo O, Vaque-Alcazar L, Videla L, Gispert JD, Suarez-Calvet M, Johnson SC, et al. APOE4 homozygozity represents a distinct genetic form of Alzheimer\u2019s disease. Nat Med. 2024. https:\/\/doi.org\/10.1038\/s41591-024-03127-y.","journal-title":"Nat Med"},{"issue":"1","key":"3349_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener. 2022;17(1):72.","journal-title":"Mol Neurodegener"},{"issue":"9","key":"3349_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"3349_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/humc.2017.231","volume":"29","author":"JB Rosenberg","year":"2018","unstructured":"Rosenberg JB, Kaplitt MG, De BP, Chen A, Flagiello T, Salami C, Pey E, Zhao L, Ricart Arbona RJ, Monette S, et al. AAVrh.10-mediated APOE2 central nervous system gene therapy for APOE4-associated Alzheimer\u2019s disease. Hum Gene Ther Clin Dev. 2018;29(1):24\u201347.","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"6","key":"3349_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.neurobiolaging.2006.12.019","volume":"29","author":"NV Ponomareva","year":"2008","unstructured":"Ponomareva NV, Korovaitseva GI, Rogaev EI. EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease. Neurobiol Aging. 2008;29(6):819\u201327.","journal-title":"Neurobiol Aging"},{"issue":"20","key":"3349_CR10","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(20):9649\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3349_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-pathmechdis-030421-112756","volume":"17","author":"N Koutsodendris","year":"2022","unstructured":"Koutsodendris N, Nelson MR, Rao A, Huang Y. Apolipoprotein E and Alzheimer\u2019s disease: findings, hypotheses, and potential mechanisms. Annu Rev Pathol. 2022;17:73\u201399.","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"3349_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrn2620","volume":"10","author":"G Bu","year":"2009","unstructured":"Bu G. Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci. 2009;10(5):333\u201344.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"3349_CR13","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/brain\/awy103","volume":"141","author":"S Mishra","year":"2018","unstructured":"Mishra S, Blazey TM, Holtzman DM, Cruchaga C, Su Y, Morris JC, Benzinger TLS, Gordon BA. Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE epsilon4 genotype. Brain. 2018;141(6):1828\u201339.","journal-title":"Brain"},{"issue":"3","key":"3349_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3233\/JAD-181282","volume":"69","author":"JB Toledo","year":"2019","unstructured":"Toledo JB, Habes M, Sotiras A, Bjerke M, Fan Y, Weiner MW, Shaw LM, Davatzikos C, Trojanowski JQ, Alzheimer\u2019s Disease Neuroimaging I. APOE effect on amyloid-beta PET spatial distribution, deposition rate, and cut-points. J Alzheimers Dis. 2019;69(3):783\u201393.","journal-title":"J Alzheimers Dis"},{"key":"3349_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neurobiolaging.2021.10.015","volume":"110","author":"MJ Novy","year":"2022","unstructured":"Novy MJ, Newbury SF, Liemisa B, Morales-Corraliza J, Alldred MJ, Ginsberg SD, Mathews PM. Expression and proteolytic processing of the amyloid precursor protein is unaffected by the expression of the three human apolipoprotein E alleles in the brains of mice. Neurobiol Aging. 2022;110:73\u20136.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"3349_CR16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s43587-021-00073-z","volume":"1","author":"A Montagne","year":"2021","unstructured":"Montagne A, Nikolakopoulou AM, Huuskonen MT, Sagare AP, Lawson EJ, Lazic D, Rege SV, Grond A, Zuniga E, Barnes SR, et al. APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer\u2019s mice via cyclophilin A independently of amyloid-beta. Nat Aging. 2021;1(6):506\u201320.","journal-title":"Nat Aging"},{"issue":"4","key":"3349_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/glia.22289","volume":"60","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Nwabuisi-Heath E, Dumanis SB, Tai LM, Yu C, Rebeck GW, LaDu MJ. APOE genotype alters glial activation and loss of synaptic markers in mice. Glia. 2012;60(4):559\u201369.","journal-title":"Glia"},{"key":"3349_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fnagi.2019.00014","volume":"11","author":"CG Fernandez","year":"2019","unstructured":"Fernandez CG, Hamby ME, McReynolds ML, Ray WJ. The role of APOE4 in disrupting the homeostatic functions of astrocytes and microglia in aging and Alzheimer\u2019s disease. Front Aging Neurosci. 2019;11:14.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"3349_CR19","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1172\/JCI112130","volume":"76","author":"JK Boyles","year":"1985","unstructured":"Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest. 1985;76(4):1501\u201313.","journal-title":"J Clin Invest"},{"issue":"4","key":"3349_CR20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/01.STR.0000064320.73388.C6","volume":"34","author":"K Aoki","year":"2003","unstructured":"Aoki K, Uchihara T, Sanjo N, Nakamura A, Ikeda K, Tsuchiya K, Wakayama Y. Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction. Stroke. 2003;34(4):875\u201380.","journal-title":"Stroke"},{"issue":"12","key":"3349_CR21","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/s41593-019-0539-4","volume":"22","author":"A Grubman","year":"2019","unstructured":"Grubman A, Chew G, Ouyang JF, Sun G, Choo XY, McLean C, Simmons RK, Buckberry S, Vargas-Landin DB, Poppe D, et al. A single-cell atlas of entorhinal cortex from individuals with Alzheimer\u2019s disease reveals cell-type-specific gene expression regulation. Nat Neurosci. 2019;22(12):2087\u201397.","journal-title":"Nat Neurosci"},{"issue":"1","key":"3349_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/jemt.1155","volume":"55","author":"P Gomez-Ramos","year":"2001","unstructured":"Gomez-Ramos P, Mufson EJ, Moran MA. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer\u2019s disease patients. Microsc Res Tech. 2001;55(1):48\u201358.","journal-title":"Microsc Res Tech"},{"issue":"5","key":"3349_CR23","doi-asserted-by":"publisher","first-page":"e1002605","DOI":"10.1371\/journal.pbio.1002605","volume":"15","author":"N Camargo","year":"2017","unstructured":"Camargo N, Goudriaan A, van Deijk AF, Otte WM, Brouwers JF, Lodder H, Gutmann DH, Nave KA, Dijkhuizen RM, Mansvelder HD, et al. Oligodendroglial myelination requires astrocyte-derived lipids. PLoS Biol. 2017;15(5):e1002605.","journal-title":"PLoS Biol"},{"issue":"1","key":"3349_CR24","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1038\/s41467-023-39046-8","volume":"14","author":"I Molina-Gonzalez","year":"2023","unstructured":"Molina-Gonzalez I, Holloway RK, Jiwaji Z, Dando O, Kent SA, Emelianova K, Lloyd AF, Forbes LH, Mahmood A, Skripuletz T, et al. Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration. Nat Commun. 2023;14(1):3372.","journal-title":"Nat Commun"},{"key":"3349_CR25","doi-asserted-by":"publisher","first-page":"e44702","DOI":"10.7554\/eLife.44702","volume":"8","author":"P Dimas","year":"2019","unstructured":"Dimas P, Montani L, Pereira JA, Moreno D, Trotzmuller M, Gerber J, Semenkovich CF, Kofeler HC, Suter U. CNS myelination and remyelination depend on fatty acid synthesis by oligodendrocytes. Elife. 2019;8:e44702.","journal-title":"Elife"},{"issue":"3","key":"3349_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1194\/jlr.R009761","volume":"52","author":"R Chrast","year":"2011","unstructured":"Chrast R, Saher G, Nave KA, Verheijen MH. Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models. J Lipid Res. 2011;52(3):419\u201334.","journal-title":"J Lipid Res"},{"issue":"6376","key":"3349_CR27","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1126\/science.aan4183","volume":"359","author":"L Cantuti-Castelvetri","year":"2018","unstructured":"Cantuti-Castelvetri L, Fitzner D, Bosch-Queralt M, Weil MT, Su M, Sen P, Ruhwedel T, Mitkovski M, Trendelenburg G, Lutjohann D, et al. Defective cholesterol clearance limits remyelination in the aged central nervous system. Science. 2018;359(6376):684\u20138.","journal-title":"Science"},{"issue":"7","key":"3349_CR28","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.neuron.2021.01.027","volume":"109","author":"S Safaiyan","year":"2021","unstructured":"Safaiyan S, Besson-Girard S, Kaya T, Cantuti-Castelvetri L, Liu L, Ji H, Schifferer M, Gouna G, Usifo F, Kannaiyan N, et al. White matter aging drives microglial diversity. Neuron. 2021;109(7):1100\u201317.","journal-title":"Neuron"},{"issue":"7","key":"3349_CR29","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/glia.23789","volume":"68","author":"S Foerster","year":"2020","unstructured":"Foerster S, de Fuente AG, Kagawa Y, Bartels T, Owada Y, Franklin RJM. The fatty acid binding protein FABP7 is required for optimal oligodendrocyte differentiation during myelination but not during remyelination. Glia. 2020;68(7):1410\u201320.","journal-title":"Glia"},{"issue":"12","key":"3349_CR30","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1002\/glia.23879","volume":"68","author":"KM Killoy","year":"2020","unstructured":"Killoy KM, Harlan BA, Pehar M, Vargas MR. FABP7 upregulation induces a neurotoxic phenotype in astrocytes. Glia. 2020;68(12):2693\u2013704.","journal-title":"Glia"},{"issue":"2","key":"3349_CR31","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s11357-023-00916-0","volume":"46","author":"HL Hamilton","year":"2024","unstructured":"Hamilton HL, Kinscherf NA, Balmer G, Bresque M, Salamat SM, Vargas MR, Pehar M. FABP7 drives an inflammatory response in human astrocytes and is upregulated in Alzheimer\u2019s disease. Geroscience. 2024;46(2):1607\u201325.","journal-title":"Geroscience"},{"issue":"1","key":"3349_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13024-022-00516-0","volume":"17","author":"TE Mahan","year":"2022","unstructured":"Mahan TE, Wang C, Bao X, Choudhury A, Ulrich JD, Holtzman DM. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Abeta accumulation and plaque-related pathology in a mouse model of amyloidosis. Mol Neurodegener. 2022;17(1):13.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"3349_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neurobiolaging.2003.03.001","volume":"25","author":"G Bartzokis","year":"2004","unstructured":"Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer\u2019s disease. Neurobiol Aging. 2004;25(1):5\u201318.","journal-title":"Neurobiol Aging"},{"key":"3349_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neuroscience.2014.02.017","volume":"276","author":"IK Amlien","year":"2014","unstructured":"Amlien IK, Fjell AM. Diffusion tensor imaging of white matter degeneration in Alzheimer\u2019s disease and mild cognitive impairment. Neuroscience. 2014;276:206\u201315.","journal-title":"Neuroscience"},{"issue":"4","key":"3349_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3233\/JAD-2011-110137","volume":"26","author":"L O'Dwyer","year":"2011","unstructured":"O\u2019Dwyer L, Lamberton F, Bokde AL, Ewers M, Faluyi YO, Tanner C, Mazoyer B, O\u2019Neill D, Bartley M, Collins DR, et al. Using diffusion tensor imaging and mixed-effects models to investigate primary and secondary white matter degeneration in Alzheimer\u2019s disease and mild cognitive impairment. J Alzheimers Dis. 2011;26(4):667\u201382.","journal-title":"J Alzheimers Dis"},{"key":"3349_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neuroscience.2017.05.048","volume":"357","author":"E Cavedo","year":"2017","unstructured":"Cavedo E, Lista S, Rojkova K, Chiesa PA, Houot M, Brueggen K, Blautzik J, Bokde ALW, Dubois B, Barkhof F, et al. Disrupted white matter structural networks in healthy older adult APOE epsilon4 carriers - an international multicenter DTI study. Neuroscience. 2017;357:119\u201333.","journal-title":"Neuroscience"},{"issue":"1","key":"3349_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13195-018-0375-x","volume":"10","author":"G Operto","year":"2018","unstructured":"Operto G, Cacciaglia R, Grau-Rivera O, Falcon C, Brugulat-Serrat A, Rodenas P, Ramos R, Moran S, Esteller M, Bargallo N, et al. White matter microstructure is altered in cognitively normal middle-aged APOE-epsilon4 homozygotes. Alzheimers Res Ther. 2018;10(1):48.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"3349_CR38","doi-asserted-by":"publisher","first-page":"e0292576","DOI":"10.1371\/journal.pone.0292576","volume":"19","author":"C Lacey","year":"2024","unstructured":"Lacey C, Paterson T, Gawryluk JR, Alzheimer\u2019s Disease Neuroimaging I. Impact of APOE-epsilon alleles on brain structure and cognitive function in healthy older adults: a VBM and DTI replication study. PLoS ONE. 2024;19(4):e0292576.","journal-title":"PLoS ONE"},{"key":"3349_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neuroimage.2015.08.007","volume":"131","author":"JC Smith","year":"2016","unstructured":"Smith JC, Lancaster MA, Nielson KA, Woodard JL, Seidenberg M, Durgerian S, Sakaie K, Rao SM. Interactive effects of physical activity and APOE-epsilon4 on white matter tract diffusivity in healthy elders. Neuroimage. 2016;131:102\u201312.","journal-title":"Neuroimage"},{"issue":"7937","key":"3349_CR40","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM, Effenberger A, Chen CY, Maner-Smith K, Hajjar I, et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature. 2022;611(7937):769\u201379.","journal-title":"Nature"},{"issue":"9","key":"3349_CR41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/jnen\/nlac054","volume":"81","author":"GW Cheng","year":"2022","unstructured":"Cheng GW, Mok KK, Yeung SH, Kofler J, Herrup K, Tse KH. Apolipoprotein E epsilon4 mediates myelin breakdown by targeting oligodendrocytes in sporadic Alzheimer disease. J Neuropathol Exp Neurol. 2022;81(9):717\u201330.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"3349_CR42","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1002\/glia.23636","volume":"67","author":"E Sock","year":"2019","unstructured":"Sock E, Wegner M. Transcriptional control of myelination and remyelination. Glia. 2019;67(11):2153\u201365.","journal-title":"Glia"},{"key":"3349_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.conb.2016.11.003","volume":"42","author":"AL Herbert","year":"2017","unstructured":"Herbert AL, Monk KR. Advances in myelinating glial cell development. Curr Opin Neurobiol. 2017;42:53\u201360.","journal-title":"Curr Opin Neurobiol"},{"issue":"4","key":"3349_CR44","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3233\/JAD-160365","volume":"53","author":"M Malek-Ahmadi","year":"2016","unstructured":"Malek-Ahmadi M, Perez SE, Chen K, Mufson EJ. Neuritic and diffuse plaque associations with memory in non-cognitively impaired elderly. J Alzheimers Dis. 2016;53(4):1641\u201352.","journal-title":"J Alzheimers Dis"},{"key":"3349_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neurobiolaging.2016.03.003","volume":"43","author":"EJ Mufson","year":"2016","unstructured":"Mufson EJ, Malek-Ahmadi M, Snyder N, Ausdemore J, Chen K, Perez SE. Braak stage and trajectory of cognitive decline in noncognitively impaired elders. Neurobiol Aging. 2016;43:101\u201310.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"3349_CR46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13195-018-0401-z","volume":"10","author":"M Malek-Ahmadi","year":"2018","unstructured":"Malek-Ahmadi M, Chen K, Perez SE, He A, Mufson EJ. Cognitive composite score association with Alzheimer\u2019s disease plaque and tangle pathology. Alzheimers Res Ther. 2018;10(1):90.","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"3349_CR47","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.neurobiolaging.2009.04.002","volume":"30","author":"JL Price","year":"2009","unstructured":"Price JL, McKeel DW Jr, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging. 2009;30(7):1026\u201336.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"3349_CR48","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Scholl","year":"2016","unstructured":"Scholl M, Lockhart SN, Schonhaut DR, O\u2019Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, et al. PET imaging of Tau deposition in the aging human brain. Neuron. 2016;89(5):971\u201382.","journal-title":"Neuron"},{"issue":"2","key":"3349_CR49","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ajpath.2011.10.027","volume":"180","author":"SE Perez","year":"2012","unstructured":"Perez SE, Getova DP, He B, Counts SE, Geula C, Desire L, Coutadeur S, Peillon H, Ginsberg SD, Mufson EJ. Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer\u2019s disease. Am J Pathol. 2012;180(2):526\u201340.","journal-title":"Am J Pathol"},{"issue":"4","key":"3349_CR50","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/00005072-199904000-00008","volume":"58","author":"DG Davis","year":"1999","unstructured":"Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol. 1999;58(4):376\u201388.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"3349_CR51","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1212\/01.WNL.0000152982.47274.9E","volume":"64","author":"DA Bennett","year":"2005","unstructured":"Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005;64(5):834\u201341.","journal-title":"Neurology"},{"issue":"2","key":"3349_CR52","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1006\/exnr.1999.7086","volume":"158","author":"EJ Mufson","year":"1999","unstructured":"Mufson EJ, Chen EY, Cochran EJ, Beckett LA, Bennett DA, Kordower JH. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol. 1999;158(2):469\u201390.","journal-title":"Exp Neurol"},{"issue":"7","key":"3349_CR53","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer\u2019s disease. Neurology. 1984;34(7):939\u201344.","journal-title":"Neurology"},{"issue":"4","key":"3349_CR54","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/archneur.1989.00520400033016","volume":"46","author":"EH Rubin","year":"1989","unstructured":"Rubin EH, Morris JC, Grant EA, Vendegna T. Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Arch Neurol. 1989;46(4):379\u201382.","journal-title":"Arch Neurol"},{"issue":"16","key":"3349_CR55","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1001\/jama.1995.03520400044042","volume":"273","author":"RC Petersen","year":"1995","unstructured":"Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT. Apolipoprotein E status as a predictor of the development of Alzheimer\u2019s disease in memory-impaired individuals. JAMA. 1995;273(16):1274\u20138.","journal-title":"JAMA"},{"issue":"6","key":"3349_CR56","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1001\/archneur.1995.00540300086018","volume":"52","author":"EM Ebly","year":"1995","unstructured":"Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol. 1995;52(6):612\u20139.","journal-title":"Arch Neurol"},{"issue":"3","key":"3349_CR57","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1532-5415.1997.tb00947.x","volume":"45","author":"DP Devanand","year":"1997","unstructured":"Devanand DP, Folz M, Gorlyn M, Moeller JR, Stern Y. Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc. 1997;45(3):321\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"3\u20134","key":"3349_CR58","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/00207459109150691","volume":"57","author":"M Albert","year":"1991","unstructured":"Albert M, Smith LA, Scherr PA, Taylor JO, Evans DA, Funkenstein HH. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer\u2019s disease. Int J Neurosci. 1991;57(3\u20134):167\u201378.","journal-title":"Int J Neurosci"},{"issue":"7","key":"3349_CR59","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.41.7.1006","volume":"41","author":"C Flicker","year":"1991","unstructured":"Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 1991;41(7):1006\u20139.","journal-title":"Neurology"},{"issue":"6","key":"3349_CR60","doi-asserted-by":"publisher","first-page":"724","DOI":"10.2174\/156720512801322591","volume":"9","author":"FA Schmitt","year":"2012","unstructured":"Schmitt FA, Nelson PT, Abner E, Scheff S, Jicha GA, Smith C, Cooper G, Mendiondo M, Danner DD, Van Eldik LJ, et al. University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr Alzheimer Res. 2012;9(6):724\u201333.","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"3349_CR61","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239\u201359.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"3349_CR62","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/00005072-199911000-00004","volume":"58","author":"KL Newell","year":"1999","unstructured":"Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol. 1999;58(11):1147\u201355.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4 Suppl","key":"3349_CR63","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1016\/S0197-4580(97)00058-4","volume":"18","author":"SS Mirra","year":"1997","unstructured":"Mirra SS. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer\u2019s disease: a commentary. Neurobiol Aging. 1997;18(4 Suppl):S91-94.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"3349_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 2012;8(1):1\u201313.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3349_CR65","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12974-020-1723-x","volume":"17","author":"M Moreno-Rodriguez","year":"2020","unstructured":"Moreno-Rodriguez M, Perez SE, Nadeem M, Malek-Ahmadi M, Mufson EJ. Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer\u2019s disease. J Neuroinflammation. 2020;17(1):58.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"3349_CR66","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12264-022-00938-2","volume":"39","author":"H Huang","year":"2023","unstructured":"Huang H, He W, Tang T, Qiu M. Immunological markers for central nervous system glia. Neurosci Bull. 2023;39(3):379\u201392.","journal-title":"Neurosci Bull"},{"issue":"6","key":"3349_CR67","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.neuron.2017.11.026","volume":"96","author":"C Sampaio-Baptista","year":"2017","unstructured":"Sampaio-Baptista C, Johansen-Berg H. White matter plasticity in the adult brain. Neuron. 2017;96(6):1239\u201351.","journal-title":"Neuron"},{"issue":"2","key":"3349_CR68","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-011-0851-x","volume":"122","author":"R Schmidt","year":"2011","unstructured":"Schmidt R, Schmidt H, Haybaeck J, Loitfelder M, Weis S, Cavalieri M, Seiler S, Enzinger C, Ropele S, Erkinjuntti T, et al. Heterogeneity in age-related white matter changes. Acta Neuropathol. 2011;122(2):171\u201385.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"3349_CR69","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm1058","volume":"10","author":"M Koistinaho","year":"2004","unstructured":"Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, Higgs R, Liu F, Malkani S, Bales KR, et al. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med. 2004;10(7):719\u201326.","journal-title":"Nat Med"},{"issue":"2","key":"3349_CR70","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3233\/JAD-170777","volume":"61","author":"R Thangavel","year":"2018","unstructured":"Thangavel R, Bhagavan SM, Ramaswamy SB, Surpur S, Govindarajan R, Kempuraj D, Zaheer S, Raikwar S, Ahmed ME, Selvakumar GP, et al. Co-expression of glia maturation factor and apolipoprotein E4 in Alzheimer\u2019s disease brain. J Alzheimers Dis. 2018;61(2):553\u201360.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"3349_CR71","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin YT, Seo J, Gao F, Feldman HM, Wen HL, Penney J, Cam HP, Gjoneska E, Raja WK, Cheng J, et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron. 2018;98(6):1141\u201354.","journal-title":"Neuron"},{"issue":"1","key":"3349_CR72","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/jnc.15748","volume":"165","author":"KK Mok","year":"2023","unstructured":"Mok KK, Yeung SH, Cheng GW, Ma IW, Lee RH, Herrup K, Tse KH. Apolipoprotein E epsilon4 disrupts oligodendrocyte differentiation by interfering with astrocyte-derived lipid transport. J Neurochem. 2023;165(1):55\u201375.","journal-title":"J Neurochem"},{"key":"3349_CR73","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/annurev-neuro-080317-061853","volume":"41","author":"M Monje","year":"2018","unstructured":"Monje M. Myelin plasticity and nervous system function. Annu Rev Neurosci. 2018;41:61\u201376.","journal-title":"Annu Rev Neurosci"},{"issue":"5","key":"3349_CR74","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1002\/alz.12831","volume":"19","author":"AJ Polsinelli","year":"2023","unstructured":"Polsinelli AJ, Logan PE, Lane KA, Manchella MK, Nemes S, Sanjay AB, Gao S, Apostolova LG. APOE epsilon4 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer\u2019s disease. Alzheimers Dement. 2023;19(5):1983\u201393.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3349_CR75","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1460-9568.2006.04855.x","volume":"24","author":"Y Owada","year":"2006","unstructured":"Owada Y, Abdelwahab SA, Kitanaka N, Sakagami H, Takano H, Sugitani Y, Sugawara M, Kawashima H, Kiso Y, Mobarakeh JI, et al. Altered emotional behavioral responses in mice lacking brain-type fatty acid-binding protein gene. Eur J Neurosci. 2006;24(1):175\u201387.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"3349_CR76","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00441-013-1730-7","volume":"354","author":"K Sharifi","year":"2013","unstructured":"Sharifi K, Ebrahimi M, Kagawa Y, Islam A, Tuerxun T, Yasumoto Y, Hara T, Yamamoto Y, Miyazaki H, Tokuda N, et al. Differential expression and regulatory roles of FABP5 and FABP7 in oligodendrocyte lineage cells. Cell Tissue Res. 2013;354(3):683\u201395.","journal-title":"Cell Tissue Res"},{"issue":"35","key":"3349_CR77","doi-asserted-by":"publisher","first-page":"27045","DOI":"10.1016\/S0021-9258(19)61478-X","volume":"275","author":"GK Balendiran","year":"2000","unstructured":"Balendiran GK, Schnutgen F, Scapin G, Borchers T, Xhong N, Lim K, Godbout R, Spener F, Sacchettini JC. Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein. J Biol Chem. 2000;275(35):27045\u201354.","journal-title":"J Biol Chem"},{"issue":"15","key":"3349_CR78","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1073\/pnas.0901515106","volume":"106","author":"M Kaczocha","year":"2009","unstructured":"Kaczocha M, Glaser ST, Deutsch DG. Identification of intracellular carriers for the endocannabinoid anandamide. Proc Natl Acad Sci U S A. 2009;106(15):6375\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"40","key":"3349_CR79","doi-asserted-by":"publisher","first-page":"24711","DOI":"10.1074\/jbc.271.40.24711","volume":"271","author":"LZ Xu","year":"1996","unstructured":"Xu LZ, Sanchez R, Sali A, Heintz N. Ligand specificity of brain lipid-binding protein. J Biol Chem. 1996;271(40):24711\u20139.","journal-title":"J Biol Chem"},{"issue":"3","key":"3349_CR80","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-191017","volume":"74","author":"N Tomaszewski","year":"2020","unstructured":"Tomaszewski N, He X, Solomon V, Lee M, Mack WJ, Quinn JF, Braskie MN, Yassine HN. Effect of APOE genotype on plasma docosahexaenoic acid (DHA), eicosapentaenoic acid, arachidonic acid, and hippocampal volume in the Alzheimer\u2019s disease cooperative study-sponsored DHA clinical trial. J Alzheimers Dis. 2020;74(3):975\u201390.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"3349_CR81","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao J, Fu Y, Yamazaki Y, Ren Y, Davis MD, Liu CC, Lu W, Wang X, Chen K, Cherukuri Y, et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids. Nat Commun. 2020;11(1):5540.","journal-title":"Nat Commun"},{"issue":"5","key":"3349_CR82","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00418-011-0865-4","volume":"136","author":"K Sharifi","year":"2011","unstructured":"Sharifi K, Morihiro Y, Maekawa M, Yasumoto Y, Hoshi H, Adachi Y, Sawada T, Tokuda N, Kondo H, Yoshikawa T, et al. FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation. Histochem Cell Biol. 2011;136(5):501\u201313.","journal-title":"Histochem Cell Biol"},{"issue":"9","key":"3349_CR83","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1242\/dev.120.9.2637","volume":"120","author":"A Kurtz","year":"1994","unstructured":"Kurtz A, Zimmer A, Schnutgen F, Bruning G, Spener F, Muller T. The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development. Development. 1994;120(9):2637\u201349.","journal-title":"Development"},{"issue":"2","key":"3349_CR84","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, Iram T, Zardeneta M, Lee SE, Lehallier B, Haney MS, Pluvinage JV, Mathur V, Hahn O, Morgens DW, et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci. 2020;23(2):194\u2013208.","journal-title":"Nat Neurosci"},{"issue":"8","key":"3349_CR85","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.1007\/s12035-019-1489-2","volume":"56","author":"A Islam","year":"2019","unstructured":"Islam A, Kagawa Y, Miyazaki H, Shil SK, Umaru BA, Yasumoto Y, Yamamoto Y, Owada Y. FABP7 protects astrocytes against ROS toxicity via lipid droplet formation. Mol Neurobiol. 2019;56(8):5763\u201379.","journal-title":"Mol Neurobiol"},{"key":"3349_CR86","doi-asserted-by":"publisher","first-page":"112293","DOI":"10.1016\/j.exger.2023.112293","volume":"182","author":"D Qiu","year":"2023","unstructured":"Qiu D, Zhou S, Donnelly J, Xia D, Zhao L. Aerobic exercise attenuates abnormal myelination and oligodendrocyte differentiation in 3xTg-AD mice. Exp Gerontol. 2023;182:112293.","journal-title":"Exp Gerontol"},{"key":"3349_CR87","doi-asserted-by":"publisher","first-page":"575082","DOI":"10.3389\/fncel.2020.575082","volume":"14","author":"I Chacon-De-La-Rocha","year":"2020","unstructured":"Chacon-De-La-Rocha I, Fryatt G, Rivera AD, Verkhratsky A, Raineteau O, Gomez-Nicola D, Butt AM. Accelerated dystrophy and decay of oligodendrocyte precursor cells in the APP\/PS1 model of Alzheimer\u2019s-like pathology. Front Cell Neurosci. 2020;14:575082.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"3349_CR88","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1006\/exnr.1999.7224","volume":"160","author":"JM Levine","year":"1999","unstructured":"Levine JM, Reynolds R. Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination. Exp Neurol. 1999;160(2):333\u201347.","journal-title":"Exp Neurol"},{"issue":"4","key":"3349_CR89","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.neuron.2010.09.009","volume":"68","author":"SH Kang","year":"2010","unstructured":"Kang SH, Fukaya M, Yang JK, Rothstein JD, Bergles DE. NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron. 2010;68(4):668\u201381.","journal-title":"Neuron"},{"issue":"1","key":"3349_CR90","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00415-019-09421-x","volume":"268","author":"N Cunniffe","year":"2021","unstructured":"Cunniffe N, Coles A. Promoting remyelination in multiple sclerosis. J Neurol. 2021;268(1):30\u201344.","journal-title":"J Neurol"},{"issue":"6079","key":"3349_CR91","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/322544a0","volume":"322","author":"K Kristensson","year":"1986","unstructured":"Kristensson K, Holmes KV, Duchala CS, Zeller NK, Lazzarini RA, Dubois-Dalcq M. Increased levels of myelin basic protein transcripts in virus-induced demyelination. Nature. 1986;322(6079):544\u20137.","journal-title":"Nature"},{"issue":"2","key":"3349_CR92","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3233\/JAD-131232","volume":"39","author":"HI Jacobs","year":"2014","unstructured":"Jacobs HI, Clerx L, Gronenschild EH, Aalten P, Verhey FR. White matter hyperintensities are positively associated with cortical thickness in Alzheimer\u2019s disease. J Alzheimers Dis. 2014;39(2):409\u201322.","journal-title":"J Alzheimers Dis"},{"key":"3349_CR93","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fncel.2020.00074","volume":"14","author":"R Tognatta","year":"2020","unstructured":"Tognatta R, Karl MT, Fyffe-Maricich SL, Popratiloff A, Garrison ED, Schenck JK, Abu-Rub M, Miller RH. Astrocytes are required for oligodendrocyte survival and maintenance of myelin compaction and integrity. Front Cell Neurosci. 2020;14:74.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"3349_CR94","first-page":"100360","volume":"4","author":"JA Barnes-Velez","year":"2023","unstructured":"Barnes-Velez JA, Aksoy Yasar FB, Hu J. Myelin lipid metabolism and its role in myelination and myelin maintenance. Innovation (Camb). 2023;4(1):100360.","journal-title":"Innovation (Camb)"},{"issue":"4","key":"3349_CR95","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3233\/JAD-231485","volume":"98","author":"M Moreno-Rodriguez","year":"2024","unstructured":"Moreno-Rodriguez M, Perez SE, Martinez-Gardeazabal J, Manuel I, Malek-Ahmadi M, Rodriguez-Puertas R, Mufson EJ. Frontal cortex lipid alterations during the onset of Alzheimer\u2019s disease. J Alzheimers Dis. 2024;98(4):1515\u201332.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"3349_CR96","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3390\/cells9040812","volume":"9","author":"Y Poitelon","year":"2020","unstructured":"Poitelon Y, Kopec AM, Belin S. Myelin fat facts: an overview of lipids and fatty acid metabolism. Cells. 2020;9(4):812.","journal-title":"Cells"},{"issue":"1","key":"3349_CR97","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13195-019-0479-y","volume":"11","author":"TJ Montine","year":"2019","unstructured":"Montine TJ, Cholerton BA, Corrada MM, Edland SD, Flanagan ME, Hemmy LS, Kawas CH, White LR. Concepts for brain aging: resistance, resilience, reserve, and compensation. Alzheimers Res Ther. 2019;11(1):22.","journal-title":"Alzheimers Res Ther"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03349-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03349-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03349-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:55:31Z","timestamp":1738277731000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-025-03349-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3349"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03349-y","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Human Research Committees of Rush University Medical Center and Dignity Health approved this study and written informed consent for research and brain autopsy was obtained from the participants or their family\/guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}